tiprankstipranks
Viskase Holdings (ENZN)
OTHER OTC:ENZN

Viskase Holdings (ENZN) Price & Analysis

92 Followers

ENZN Stock Chart & Stats

$5.99
<$0.01(0.44%)
At close: 4:00 PM EST
$5.99
<$0.01(0.44%)

Viskase Holdings News

ENZN FAQ

What was Viskase Holdings’s price range in the past 12 months?
Viskase Holdings lowest stock price was $1.53 and its highest was $11.12 in the past 12 months.
    What is Viskase Holdings’s market cap?
    Viskase Holdings’s market cap is $63.06M.
      When is Viskase Holdings’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Viskase Holdings’s earnings last quarter?
      Currently, no data Available
      Is Viskase Holdings overvalued?
      According to Wall Street analysts Viskase Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Viskase Holdings pay dividends?
        Viskase Holdings pays a Semiannually dividend of $12 which represents an annual dividend yield of N/A. See more information on Viskase Holdings dividends here
          What is Viskase Holdings’s EPS estimate?
          Viskase Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Viskase Holdings have?
          Viskase Holdings has 14,331,620 shares outstanding.
            What happened to Viskase Holdings’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Viskase Holdings?
            Currently, no hedge funds are holding shares in ENZN
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Viskase Holdings

              Viskase Companies, Inc., together with its subsidiaries, produces and sells non-edible cellulosic, fibrous, and plastic casings for preparing and packaging processed meat products and services in North America, South America, Europe, Asia, and internationally. The company offers NOJAX cellulose casings for use in the automated production of hot dogs, dry mini salamis, and cooked and coarse ground sausages; and large cellulose casings to give cylindrical or oval shape to the processed meats that are used in bologna, mortadella, deli ham, bierwurst, and dry sausages. It also provides VISDRY casings for dried or smoked sausages; VISFLEX casings for cheese and processed meat applications; VISMAX casings for molded, and formed processed meat and poultry applications; VISLON for meat, poultry, and cheese applications; VISMOKE casings for cooked and smoked meat products, semi-dry sausages, and spreadable dry sausages; VISCOAT casings for a range of applications, including turkey, ham, and roast beef products; and POLYJAX casings for the production of hot dog, sausage, chorizo products, and meat snack sticks. In addition, the company provides fibrous casings for use in a range of applications, including pepperoni, salami, boneless hams, luncheon meats, and other deli-style processed meats, as well as for processed and smoked cheeses; color transfer casings for a range of natural and synthetic shades; flavor transfer casings for taste profiles; smoke transfer casings for processed meat or cheese products; and spice transfer casings for processing facility. Additionally, it offers textile spice transfer casings for transfer of the spice to the food; Ve-Net products; and MEMBRA-CEL, a dialysis membranes made from regenerated cellulose. The company was founded in 1925 and is based in Lombard, Illinois. Viskase Companies, Inc. is a subsidiary of Icahn Enterprises L.P.
              Similar Stocks
              Company
              Price & Change
              Follow
              AIM ImmunoTech
              GT Biopharma
              PharmaCyte Biotech
              Processa Pharmaceuticals

              Ownership Overview

              93.68%6.32%
              93.68% Insiders
              ― Other Institutional Investors
              6.32% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks